Clinical Trial Update: Ursodiol for Treating Parenteral Nutrition Associated Cholestasis in Neonates [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating Ursodiol (ursodeoxycholic acid) for parenteral nutrition-associated cholestasis in neonates has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Cholestasis
• Parenteral Nutrition Associated Cholestasis

Drugs mentioned

• URSODIOL (ursodiol)

Snippet

Sponsor: Ibrahim Mohamed | Conditions: Cholestasis | Phase 2, Phase 3 | Status: COMPLETED